MASH Clinical Guidelines for APPs
Access expert-led MASH tools for diagnosis, staging, and management. Developed by GHAPP faculty specifically for APPs in community GI and li
As MASH transforms metabolic liver care, MASH Clinical Guidelines for APPs are crucial for integrating structured, evidence-based metabolic liver care. MASH is quickly becoming a leading cause for advanced liver disease, such as cirrhosis, and advanced practice providers (APPs) are the primary clinicians that oversee masses of patients suffering from the metabolic disease of obesity, type 2 diabetes, hypertension, and dyslipidemia. APPs are first contact clinicians for primary and specialty care, which is why the MASH clinical guidelines for APPs are valuable to help clinicians practice their skill sets to the fullest and ensure they Perform early detection and proper staging of MASH, effective management and treatment, monitoring of long-term progression, and apply the best practices of metabolic liver care. APPs now have the needed confidence to span the continuum of care and implement MASH care management, thanks to expert-led education, digital guides, and collaborative practice at the MASLD Community Network.
MASH clinical guidelines for APPs offer the resources to diagnose, stage, create treatment plans, monitor disease, and implement best practices in the metabolic care of the liver. APPs, as frontline clinicians managing patients with multiple complex cardiometabolic conditions, have a critical involvement in the liver-related complication and the overall health burden. Advanced Practice Providers (APPs) through the MASLD Community Network, and structured care pathways, and non-invasive risk stratification, multidisciplinary team (MDT) collaboration, and ongoing education, are equipped to provide confident, consistent, and real MASH impact.